Global PCR and NGS-based Diagnostics Market (2021 to 2027) - Industry Analysis, Trends, Market Size and Forecasts - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 3, 2021--
The “PCR and NGS-based Diagnostics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027” report has been added to ResearchAndMarkets.com’s offering.
The report on the global PCR and NGS-based diagnostics market provides qualitative and quantitative analysis for the period from 2019 to 2027. The report predicts the global PCR and NGS-based diagnostics market to grow with a CAGR of 10.4% over the forecast period from 2021-2027. The study on PCR and NGS-based diagnostics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2019 to 2027.
The report on PCR and NGS-based diagnostics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global PCR and NGS-based diagnostics market over the period of 2019 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global PCR and NGS-based diagnostics market over the period of 2019 to 2027. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
The global PCR and NGS-based diagnostics market is segmented on the basis of product, application, and end user.
The Global PCR and NGS-based Diagnostics Market by Product
- Reagents & Kits
- Services & Software
The Global PCR and NGS-based Diagnostics Market by Application
- Infectious Disease Diagnostics
- Genetic Tests
- Oncology Testing
The Global PCR and NGS-based Diagnostics Market by End User
- Hospitals and Clinics
- Diagnostic Centers
What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the PCR and NGS-based diagnostics market.
2. Complete coverage of all the segments in the PCR and NGS-based diagnostics market to analyze the trends, developments in the global market and forecast of market size up to 2027.
3. Comprehensive analysis of the companies operating in the global PCR and NGS-based diagnostics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
- Rise in the prevalence of infectious diseases
- Growing R&D and funding in molecular diagnostics
- Lack of skilled professionals in low- and middle-income countries
- Transforming healthcare infrastructure in developing regions
- Bio-Rad Laboratories, Inc.
- Eppendorf AG
- F. Hoffmann-La Roche AG
- Abbott Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Agilent Technologies Inc.
- Molbio Diagnostics Pvt. Ltd.
- Amoy Diagnostics Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/ytptcq
View source version on businesswire.com:https://www.businesswire.com/news/home/20210903005320/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: BIOTECHNOLOGY GENETICS HEALTH OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2021.
PUB: 09/03/2021 10:53 AM/DISC: 09/03/2021 10:53 AM